Ryght AI Launches Global Clinical Trial Site Network with the University of Southern California as their First Academic Site.

Keck School of Medicine of USC membership will bolster the ranks of academic and community hospitals joining the Ryght Research Network to streamline clinical trials with AI

LAGUNA BEACH, Calif., Dec. 17, 2024 /PRNewswire/ -- Ryght, a real-time generative AI healthcare technology provider for the clinical research industry, announced today the launch of "The Ryght Research Network", a global network of clinical research sites. The network includes a growing number of academic institutions, community practices, and healthcare systems of all sizes, across all geographies, covering all therapeutic areas with the intention of providing real-time communications between all trial stakeholders to accelerate clinical trial timelines with AI.

Clinical trials are inefficient and overburdened by manual tasks, causing staff burnout and turnover, with 30% of Clinical Research Associates leaving their roles. In oncology, 80% of research programs face severe staffing shortages, while site teams spend 40% of their time on administrative work. These issues lead to a significant number of trial sites failing to enroll even one patient, resulting in delayed therapies and increased trial failures.

"We are delighted to join the Ryght Research Network," said David Friedland, M.D, Ph.D., Associate Dean of Clinical Research, Keck School of Medicine of USC. "We aim to transform clinical trial operations through AI. By streamlining site selection, feasibility, and patient referrals, the Ryght Research Network will allow us to focus more on advancing patient care and less on administrative burden while running the trials that are most likely to succeed. This partnership enables Keck School of Medicine of USC to be at the forefront of innovative, efficient research, helping bring therapies to patients faster and supporting our mission to improve global health outcomes."

The Ryght Research Network is a global network connecting clinical research sites of all sizes across various geographies and therapeutic areas on one end and clinical trial sponsors on the other. Leveraging Ryght's advanced generative AI capabilities, Ryght AI processes site-specific and industry-wide data to deliver real-time insights that empower sites to make data-driven decisions - all while keeping site data secure.

By automating crucial tasks like feasibility assessments, site selection, patient referrals, and facilitating real-time communication between sites and sponsors, traditional trial workflows are transformed. It not only simplifies trial management for research sites but also accelerates ideal site selection for sponsors and ideal patient selection, ultimately setting up both the site and sponsor for success.

"We are thrilled to welcome Keck School of Medicine of USC to the Ryght Research Network," said Chadi Nabhan, MD, MBA, Chief Medical Officer and Head of Strategy at Ryght. "We share the same vision with the Keck School of Medicine of USC in aiming to advance clinical research by expediting trial processes to improve the outcomes of all patients affected by cancer. Leveraging AI technology and innovation can accomplish that in a timely manner."

About Ryght:

Ryght AI, the real-time clinical trials company, is a privately held healthcare technology company with the next generation of safe and secure generative artificial intelligence (GenAI) solutions for the clinical research industry. Ryght's platform and customized research applications streamline clinical trials, accelerate workflows, and provide real-time communication for trial sites, sponsors, and CROs. The Ryght platform optimizes multiple large language models (LLMs) and GenAI services to ingest large and real-time data streams and make actionable knowledge directly available to all stakeholders in the clinical research industry.  For more information, please visit the company's website at www.ryght.ai. To discuss custom development and collaboration, please email [email protected].

Media Contact

Alexia Krispin

[email protected]

SOURCE Ryght